Skip to content
Trial Eligibility
Menu

Concomitant Renal and Urinary Bladder Allograft Transplantation

NCT04626167

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to establish if concomitant renal and vascularized urinary bladder allograft transplantation is feasible.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Chronic Kidney Diseases
  • Bladder Dysfunction
  • Bladder Absence
  • Posterior Urethral Valve
  • Neurogenic Bladder
  • Bladder Exstrophy
  • Bladder Outlet Obstruction
  • Failure, Kidney
  • Transplant

Eligibility basics and study details

Study type
Interventional
Phase
Early Phase 1
Ages
1 year to 60 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Mayo Clinic
Last updated on ClinicalTrials.gov
September 24, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Minnesota · 2

  • Mayo Clinic · Rochester, MN
  • Mayo Clinic in Rochester · Rochester, MN

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.